PDF(Pubmed)
Abstract：
UNASSIGNED: An increasing number of studies have proved that patent foramen ovale (PFO) occlusion could reduce the incidence of recurrent stroke more than drug therapy alone under certain conditions. Which is the \"best\" guidance technique still remains to be discussed.
UNASSIGNED: A single center retrospective study enrolled 120 patients (mean age 52.51 ± 14.29 years) who underwent PFO closure between April 2019 and March 2021. 87 patients (72.5%) had suffered cryptogenic stroke (CS) at least one time, and 24 patients (20%) had repetitive episodes of hemicrania unsourced. 65 patients were in the transesophageal echocardiography (TEE) guidance group (T-group), and the other 55 patients were in the angiographic guidance group (A-group).
UNASSIGNED: There were no significant differences in crucial clinical characteristics between the two groups. In T-group, the procedural success rate was higher (100% vs. 92.7%, P = 0.028), and the procedural time was shorter (23.15 ± 13.87 vs. 25.75 ± 7.19, P = 0.001). No difference was detected in the procedural complication rate. Follow-up were performed at least 12 months. At 12 months, new atrial fibrillation occurred in 1 patient (1.5%) in the T-group and in 1 patient (1.8%) in the A-group (P = 0.905). Residual shunt occurred in 1 patient (1.5%) in the T-group and in 3 patients (5.5%) in the A-group (P = 0.236). Recurrent cerebral ischemia occurred in 2 patient (3.1%) in the T-group and in 2 patients (3.6%) in the A-group (P = 0.865).
UNASSIGNED: The use of only intra-procedural TEE guidance for PFO closure is safe and effective. The whole procedure can be performed without fluoroscopy and contrast medium. The short and medium follow-up results are satisfactory, especially in the residual shunt.
UNASSIGNED: A single center retrospective study enrolled 120 patients (mean age 52.51 ± 14.29 years) who underwent PFO closure between April 2019 and March 2021. 87 patients (72.5%) had suffered cryptogenic stroke (CS) at least one time, and 24 patients (20%) had repetitive episodes of hemicrania unsourced. 65 patients were in the transesophageal echocardiography (TEE) guidance group (T-group), and the other 55 patients were in the angiographic guidance group (A-group).
UNASSIGNED: There were no significant differences in crucial clinical characteristics between the two groups. In T-group, the procedural success rate was higher (100% vs. 92.7%, P = 0.028), and the procedural time was shorter (23.15 ± 13.87 vs. 25.75 ± 7.19, P = 0.001). No difference was detected in the procedural complication rate. Follow-up were performed at least 12 months. At 12 months, new atrial fibrillation occurred in 1 patient (1.5%) in the T-group and in 1 patient (1.8%) in the A-group (P = 0.905). Residual shunt occurred in 1 patient (1.5%) in the T-group and in 3 patients (5.5%) in the A-group (P = 0.236). Recurrent cerebral ischemia occurred in 2 patient (3.1%) in the T-group and in 2 patients (3.6%) in the A-group (P = 0.865).
UNASSIGNED: The use of only intra-procedural TEE guidance for PFO closure is safe and effective. The whole procedure can be performed without fluoroscopy and contrast medium. The short and medium follow-up results are satisfactory, especially in the residual shunt.
摘要：
UNASSIGNED：越来越多的研究证明，卵圆孔未闭（PFO）闭塞在某些条件下比单独药物治疗更能降低复发性中风的发生率。哪一种是“最好的”制导技术还有待讨论。
UNASSIGNED：一项单中心回顾性研究纳入了在2019年4月至2021年3月期间接受PFO封堵的120例患者（平均年龄52.51±14.29岁）。87例(72.5%)患者至少有1次患有隐源性卒中(CS),24例患者（20％）有反复发作的偏头痛。经食管超声心动图(TEE)指导组(T组)65例,其他55例患者在血管造影指导组（A组）。
UNASSIGNED：两组之间的关键临床特征没有显着差异。在T组,手术成功率较高(100%vs.92.7%,P=0.028),手术时间较短(23.15±13.87vs.25.75±7.19,P=0.001)。手术并发症发生率无差异。随访至少12个月。12个月时,T组1例患者(1.5%)和A组1例患者(1.8%)出现新的心房颤动(P=0.905).T组1例(1.5%)和A组3例(5.5%)发生残余分流(P=0.236)。T组2例（3.1％）和A组2例（3.6％）发生复发性脑缺血（P=0.865）。
UNASSIGNED：仅使用术中TEE指导进行PFO闭合是安全有效的。整个过程可以在没有荧光透视和造影剂的情况下进行。中短随访结果令人满意,尤其是在残余分流中。
UNASSIGNED：一项单中心回顾性研究纳入了在2019年4月至2021年3月期间接受PFO封堵的120例患者（平均年龄52.51±14.29岁）。87例(72.5%)患者至少有1次患有隐源性卒中(CS),24例患者（20％）有反复发作的偏头痛。经食管超声心动图(TEE)指导组(T组)65例,其他55例患者在血管造影指导组（A组）。
UNASSIGNED：两组之间的关键临床特征没有显着差异。在T组,手术成功率较高(100%vs.92.7%,P=0.028),手术时间较短(23.15±13.87vs.25.75±7.19,P=0.001)。手术并发症发生率无差异。随访至少12个月。12个月时,T组1例患者(1.5%)和A组1例患者(1.8%)出现新的心房颤动(P=0.905).T组1例(1.5%)和A组3例(5.5%)发生残余分流(P=0.236)。T组2例（3.1％）和A组2例（3.6％）发生复发性脑缺血（P=0.865）。
UNASSIGNED：仅使用术中TEE指导进行PFO闭合是安全有效的。整个过程可以在没有荧光透视和造影剂的情况下进行。中短随访结果令人满意,尤其是在残余分流中。
